发明名称 NUCLEIC ACID PARTICIPATING IN THE FORMATION OF PRESENILIN-2-GENE EXON 5-DEFECTIVE SPLICING VARIANT
摘要 Means of treating and/or preventing diseases caused by a splicing variant, neurodegenerative diseases typified by Alzheimer~s disease and so on. A nucleic acid seemingly participating in the formation of a presenilin-2 exon 5- deficient splicing variant; an inhibitor inhibiting the binding between a protein and a nucleic acid causing the splicing variant; and a method of screening the inhibitor.
申请公布号 CA2451959(A1) 申请公布日期 2003.01.09
申请号 CA20022451959 申请日期 2002.06.27
申请人 JAPAN SCIENCE AND TECHNOLOGY AGENCY;TAISHO PHARMACEUTICAL CO. LTD. 发明人 TOHYAMA, MASAYA;IMAIZUMI, KAZUNORI;IKEDA, YOKO;MANABE, TAKAYUKI;KATAYAMA, TAIICHI
分类号 G01N33/50;A61K31/7088;A61K45/00;A61K48/00;A61P25/28;A61P43/00;C07K14/47;C12N15/09;C12N15/12;C12Q1/68;G01N33/15;G01N33/53;G01N33/566;G01N33/68;(IPC1-7):C12N15/12 主分类号 G01N33/50
代理机构 代理人
主权项
地址